Antiparkinsonian effect of flupirtine in monoamine-depleted rats
- 1 May 1996
- journal article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 103 (5) , 581-590
- https://doi.org/10.1007/bf01273155
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Influence of flupirtine on human lower limb reflexesElectroencephalography and Clinical Neurophysiology/Electromyography and Motor Control, 1995
- The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-d-aspartate and gp120 of HIV-1European Journal of Pharmacology: Molecular Pharmacology, 1994
- Flupirtine protects against ischaemic retinal dysfunction in ratsNeuroReport, 1994
- N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of flupirtine in ratsNeuroReport, 1994
- Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's diseaseAnnals of Neurology, 1994
- Toward an understanding of the role of glutamate in experimental parkinsonism: Agonist‐sensitive sites in the basal gangliaAnnals of Neurology, 1993
- FlupirtineDrugs, 1993
- The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in ratsPharmacology Biochemistry and Behavior, 1989
- Medium and long latency EMG responses in leg muscles: Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1987